John Hellerstedt
John Hellerstedt, M.D., serves as Commissioner of the Texas Department of State Health Services, leading one of the state’s largest agencies with a staff of 12,000 and an annual budget of $3.3 billion. As Commissioner, Dr. Hellerstedt oversees programs such as disease prevention and disaster preparedness, community health services, environmental and consumer safety, state mental health facilities and regulatory programs. Dr. Hellerstedt became Commissioner on January 4, 2016.
Prior to becoming Commissioner, Dr. Hellerstedt served as Chief Medical Officer at Seton Family of Hospitals. He also served as the Vice President of Medical Affairs for Dell Children’s Medical Center of Central Texas and as the Medical Director of Texas Medicaid and Children’s Health Insurance Program at the Texas Health and Human Services Commission.
Dr. Hellerstedt earned a Bachelor of Science in chemistry, graduating with high honors from Allegheny College, and received his medical degree from Pittsburgh School of Medicine. Dr. Hellerstedt completed his residency in general pediatrics at the University of Texas at San Antonio Health Science Center, and is certified by the American Board of Pediatrics.
From A to Zika: Are you Prepared for this Disease…and the Next One?


For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































